RENULYS Trademark

Trademark Overview

On Friday, August 6, 2021, a trademark application was filed for RENULYS with the United States Patent and Trademark Office. The USPTO has given the RENULYS trademark a serial number of 90870155. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Thursday, July 11, 2024. This trademark is owned by Pfizer Inc.. The RENULYS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of alopecia areata, vitiligo, irritable bowel disease, ulcerative colitis, Crohn's disease and rheumatoid arthritis; pharmaceutical preparations for the treatment of autoimmune and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of skin disorders; and dermatological pharmaceutical preparations
renulys

General Information

Serial Number90870155
Word MarkRENULYS
Filing DateFriday, August 6, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateThursday, July 11, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 7, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of alopecia areata, vitiligo, irritable bowel disease, ulcerative colitis, Crohn's disease and rheumatoid arthritis; pharmaceutical preparations for the treatment of autoimmune and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of skin disorders; and dermatological pharmaceutical preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 30, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Tuesday, August 10, 2021NEW APPLICATION ENTERED
Thursday, September 30, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 5, 2022ASSIGNED TO EXAMINER
Thursday, May 5, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 18, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 7, 2022PUBLISHED FOR OPPOSITION
Tuesday, June 7, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 2, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 25, 2023SOU EXTENSION 1 FILED
Wednesday, January 25, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, January 25, 2023SOU EXTENSION 1 GRANTED
Friday, January 27, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 28, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 28, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 28, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 28, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 28, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 6, 2023SOU TEAS EXTENSION RECEIVED
Thursday, July 6, 2023SOU EXTENSION 2 FILED
Thursday, July 6, 2023SOU EXTENSION 2 GRANTED
Saturday, July 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 16, 2024SOU EXTENSION 3 GRANTED
Tuesday, January 16, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, January 16, 2024SOU EXTENSION 3 FILED
Thursday, July 11, 2024SOU TEAS EXTENSION RECEIVED
Thursday, July 11, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 11, 2024SOU EXTENSION 4 GRANTED
Thursday, July 11, 2024SOU EXTENSION 4 FILED
Thursday, January 18, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

renulys preparations pharmaceutical treatment disorders diseases disease rheumatoid arthritis skin dermatological